| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insurance, Health | 46 | 2021 | 95 | 13.590 |
Why?
|
| Health Care Reform | 23 | 2017 | 44 | 5.500 |
Why?
|
| Insurance Coverage | 22 | 2021 | 75 | 5.040 |
Why?
|
| United States | 114 | 2022 | 3925 | 4.880 |
Why?
|
| Trust | 22 | 2021 | 43 | 3.500 |
Why?
|
| Medically Uninsured | 13 | 2013 | 31 | 3.480 |
Why?
|
| Managed Care Programs | 17 | 2012 | 41 | 3.330 |
Why?
|
| Physician-Patient Relations | 24 | 2021 | 184 | 3.290 |
Why?
|
| State Government | 21 | 2020 | 30 | 3.200 |
Why?
|
| Health Services Accessibility | 17 | 2020 | 242 | 3.090 |
Why?
|
| Health Benefit Plans, Employee | 9 | 2018 | 12 | 2.990 |
Why?
|
| Insurance Carriers | 15 | 2019 | 18 | 2.750 |
Why?
|
| Physicians | 13 | 2021 | 157 | 2.480 |
Why?
|
| Liability, Legal | 11 | 2022 | 24 | 2.440 |
Why?
|
| Humans | 134 | 2022 | 31836 | 2.180 |
Why?
|
| Government Regulation | 12 | 2019 | 29 | 2.060 |
Why?
|
| Mandatory Programs | 5 | 2012 | 5 | 1.910 |
Why?
|
| Politics | 10 | 2014 | 22 | 1.900 |
Why?
|
| Civil Rights | 4 | 2020 | 7 | 1.850 |
Why?
|
| Health Expenditures | 6 | 2019 | 66 | 1.850 |
Why?
|
| Patient Rights | 9 | 2016 | 12 | 1.810 |
Why?
|
| Supreme Court Decisions | 4 | 2015 | 5 | 1.790 |
Why?
|
| Malpractice | 7 | 2022 | 21 | 1.730 |
Why?
|
| Health Care Costs | 7 | 2020 | 117 | 1.650 |
Why?
|
| Coronavirus Infections | 4 | 2020 | 99 | 1.590 |
Why?
|
| Pneumonia, Viral | 4 | 2020 | 103 | 1.590 |
Why?
|
| Health Policy | 10 | 2020 | 82 | 1.560 |
Why?
|
| Health Care Sector | 8 | 2013 | 18 | 1.530 |
Why?
|
| Biomedical Research | 10 | 2010 | 155 | 1.340 |
Why?
|
| Insurance Selection Bias | 8 | 2016 | 8 | 1.320 |
Why?
|
| Conflict of Interest | 12 | 2010 | 35 | 1.270 |
Why?
|
| Delivery of Health Care | 8 | 2009 | 159 | 1.190 |
Why?
|
| Commerce | 3 | 2012 | 43 | 1.170 |
Why?
|
| National Health Insurance, United States | 3 | 2017 | 4 | 1.020 |
Why?
|
| Ethics, Research | 7 | 2010 | 15 | 0.990 |
Why?
|
| Public Health | 3 | 2020 | 81 | 0.970 |
Why?
|
| Financial Management | 2 | 2015 | 2 | 0.950 |
Why?
|
| Health Maintenance Organizations | 9 | 2016 | 13 | 0.930 |
Why?
|
| Prejudice | 5 | 2007 | 50 | 0.930 |
Why?
|
| Fees and Charges | 6 | 2021 | 14 | 0.930 |
Why?
|
| Communicable Disease Control | 2 | 2020 | 15 | 0.900 |
Why?
|
| Social Justice | 5 | 2015 | 17 | 0.900 |
Why?
|
| Disclosure | 11 | 2009 | 31 | 0.890 |
Why?
|
| Rate Setting and Review | 4 | 2015 | 6 | 0.890 |
Why?
|
| Informed Consent | 8 | 2021 | 34 | 0.870 |
Why?
|
| Confidentiality | 10 | 2010 | 29 | 0.870 |
Why?
|
| Emigration and Immigration | 2 | 2020 | 31 | 0.860 |
Why?
|
| Patients | 6 | 2008 | 46 | 0.850 |
Why?
|
| Patient Satisfaction | 8 | 2008 | 240 | 0.840 |
Why?
|
| Legislation, Medical | 4 | 2004 | 6 | 0.840 |
Why?
|
| Taxes | 2 | 2012 | 4 | 0.830 |
Why?
|
| Decision Making | 8 | 2015 | 194 | 0.820 |
Why?
|
| Ownership | 3 | 2009 | 15 | 0.820 |
Why?
|
| Cost Control | 4 | 2014 | 18 | 0.810 |
Why?
|
| Insurance Pools | 3 | 2011 | 3 | 0.790 |
Why?
|
| Quarantine | 2 | 2020 | 3 | 0.780 |
Why?
|
| Attitude to Health | 7 | 2017 | 165 | 0.780 |
Why?
|
| Patient Advocacy | 6 | 2008 | 12 | 0.770 |
Why?
|
| Health Insurance Portability and Accountability Act | 4 | 2010 | 5 | 0.770 |
Why?
|
| Local Government | 1 | 2020 | 5 | 0.750 |
Why?
|
| Primary Health Care | 6 | 2012 | 225 | 0.750 |
Why?
|
| Financing, Personal | 3 | 2021 | 6 | 0.730 |
Why?
|
| Income Tax | 2 | 2010 | 2 | 0.730 |
Why?
|
| Public Health Administration | 1 | 2020 | 3 | 0.730 |
Why?
|
| Viral Vaccines | 1 | 2020 | 11 | 0.720 |
Why?
|
| Adaptive Immunity | 1 | 2020 | 16 | 0.720 |
Why?
|
| Genetic Testing | 9 | 2008 | 96 | 0.720 |
Why?
|
| Hospitals, Community | 2 | 2011 | 11 | 0.720 |
Why?
|
| Documentation | 1 | 2020 | 46 | 0.700 |
Why?
|
| Private Sector | 4 | 2016 | 8 | 0.690 |
Why?
|
| Medicaid | 4 | 2014 | 94 | 0.690 |
Why?
|
| Referral and Consultation | 3 | 2013 | 140 | 0.680 |
Why?
|
| Insurance Claim Review | 4 | 2014 | 27 | 0.650 |
Why?
|
| Hemochromatosis | 6 | 2008 | 70 | 0.640 |
Why?
|
| Refusal to Treat | 2 | 2016 | 2 | 0.630 |
Why?
|
| Moral Obligations | 2 | 2016 | 2 | 0.630 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2009 | 37 | 0.630 |
Why?
|
| Mass Screening | 2 | 2020 | 263 | 0.610 |
Why?
|
| Forecasting | 5 | 2017 | 144 | 0.600 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2005 | 168 | 0.600 |
Why?
|
| Risk Adjustment | 4 | 2015 | 26 | 0.590 |
Why?
|
| Quality of Health Care | 7 | 2015 | 147 | 0.590 |
Why?
|
| Economic Competition | 6 | 2019 | 9 | 0.590 |
Why?
|
| Federal Government | 7 | 2015 | 8 | 0.590 |
Why?
|
| Public Policy | 7 | 2015 | 31 | 0.590 |
Why?
|
| State Health Plans | 1 | 2017 | 5 | 0.580 |
Why?
|
| Academic Medical Centers | 6 | 2010 | 156 | 0.580 |
Why?
|
| Interpersonal Relations | 7 | 2004 | 57 | 0.580 |
Why?
|
| Interviews as Topic | 11 | 2015 | 262 | 0.570 |
Why?
|
| Financing, Government | 3 | 2015 | 10 | 0.570 |
Why?
|
| Jurisprudence | 4 | 2013 | 7 | 0.560 |
Why?
|
| Cost Savings | 3 | 2012 | 34 | 0.560 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2010 | 353 | 0.560 |
Why?
|
| Hospital Charges | 2 | 2013 | 15 | 0.560 |
Why?
|
| Blue Cross Blue Shield Insurance Plans | 3 | 2006 | 5 | 0.550 |
Why?
|
| Hispanic Americans | 3 | 2017 | 942 | 0.550 |
Why?
|
| Ethics Committees, Research | 7 | 2010 | 12 | 0.550 |
Why?
|
| Social Class | 4 | 2020 | 88 | 0.550 |
Why?
|
| Conscience | 1 | 2016 | 1 | 0.550 |
Why?
|
| Adult | 27 | 2021 | 9327 | 0.540 |
Why?
|
| Abortion, Induced | 1 | 2016 | 6 | 0.540 |
Why?
|
| Legislation as Topic | 3 | 2005 | 5 | 0.520 |
Why?
|
| Clinical Trials as Topic | 5 | 2010 | 297 | 0.500 |
Why?
|
| Costs and Cost Analysis | 2 | 2012 | 100 | 0.490 |
Why?
|
| Health Care Surveys | 7 | 2005 | 186 | 0.490 |
Why?
|
| Investments | 2 | 2006 | 3 | 0.490 |
Why?
|
| Organizations, Nonprofit | 2 | 2006 | 6 | 0.490 |
Why?
|
| Law Enforcement | 1 | 2015 | 26 | 0.490 |
Why?
|
| Health Services | 1 | 2015 | 38 | 0.490 |
Why?
|
| Patient Selection | 3 | 2010 | 276 | 0.470 |
Why?
|
| Risk Management | 2 | 2012 | 27 | 0.470 |
Why?
|
| Motivation | 5 | 2005 | 111 | 0.470 |
Why?
|
| Contracts | 5 | 2012 | 6 | 0.460 |
Why?
|
| Ethics | 4 | 2005 | 5 | 0.450 |
Why?
|
| Obesity, Morbid | 2 | 2005 | 71 | 0.450 |
Why?
|
| Accounting | 1 | 2013 | 1 | 0.440 |
Why?
|
| Reimbursement Mechanisms | 1 | 2013 | 13 | 0.440 |
Why?
|
| Medicine | 1 | 2013 | 38 | 0.430 |
Why?
|
| Health Services Research | 7 | 2006 | 82 | 0.430 |
Why?
|
| Constitution and Bylaws | 2 | 2011 | 3 | 0.430 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2007 | 835 | 0.430 |
Why?
|
| Research Personnel | 3 | 2009 | 15 | 0.430 |
Why?
|
| Social Welfare | 2 | 2003 | 3 | 0.420 |
Why?
|
| Public Opinion | 2 | 2014 | 17 | 0.410 |
Why?
|
| Fees, Medical | 2 | 2009 | 2 | 0.400 |
Why?
|
| Models, Organizational | 1 | 2011 | 15 | 0.390 |
Why?
|
| Emigrants and Immigrants | 1 | 2015 | 245 | 0.390 |
Why?
|
| Family Practice | 2 | 2009 | 51 | 0.390 |
Why?
|
| Employee Retirement Income Security Act | 4 | 2005 | 5 | 0.390 |
Why?
|
| Alcoholism | 2 | 2022 | 101 | 0.380 |
Why?
|
| Economics | 4 | 1996 | 6 | 0.360 |
Why?
|
| Focus Groups | 5 | 2015 | 114 | 0.360 |
Why?
|
| Genetic Privacy | 3 | 2000 | 3 | 0.350 |
Why?
|
| Tissue Banks | 1 | 2010 | 15 | 0.350 |
Why?
|
| Internationality | 1 | 2010 | 21 | 0.350 |
Why?
|
| Female | 23 | 2017 | 19859 | 0.350 |
Why?
|
| Research Subjects | 6 | 2010 | 17 | 0.350 |
Why?
|
| Data Collection | 7 | 2010 | 180 | 0.340 |
Why?
|
| Empathy | 1 | 2009 | 19 | 0.340 |
Why?
|
| Medicare | 4 | 2014 | 206 | 0.340 |
Why?
|
| Male | 22 | 2017 | 19091 | 0.330 |
Why?
|
| Medical Savings Accounts | 2 | 2005 | 2 | 0.330 |
Why?
|
| Ethics, Business | 1 | 2008 | 2 | 0.330 |
Why?
|
| Ethics, Professional | 1 | 2008 | 8 | 0.330 |
Why?
|
| Needs Assessment | 2 | 2013 | 76 | 0.330 |
Why?
|
| Middle Aged | 20 | 2017 | 11824 | 0.330 |
Why?
|
| Physician Incentive Plans | 3 | 2004 | 4 | 0.320 |
Why?
|
| Consumer Advocacy | 1 | 2008 | 3 | 0.310 |
Why?
|
| North Carolina | 8 | 2017 | 1514 | 0.310 |
Why?
|
| Human Experimentation | 2 | 2007 | 4 | 0.310 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2010 | 251 | 0.310 |
Why?
|
| Attitude of Health Personnel | 3 | 2010 | 180 | 0.290 |
Why?
|
| Employment | 1 | 2007 | 48 | 0.290 |
Why?
|
| Job Satisfaction | 1 | 2007 | 40 | 0.290 |
Why?
|
| Resource Allocation | 3 | 2002 | 9 | 0.290 |
Why?
|
| Refusal to Participate | 1 | 2007 | 4 | 0.290 |
Why?
|
| Ethics, Medical | 5 | 2008 | 18 | 0.280 |
Why?
|
| Health Services Needs and Demand | 2 | 2005 | 81 | 0.270 |
Why?
|
| Psychometrics | 3 | 2004 | 136 | 0.270 |
Why?
|
| Bioethical Issues | 2 | 2006 | 3 | 0.270 |
Why?
|
| Genetic Counseling | 3 | 2000 | 8 | 0.260 |
Why?
|
| Research | 1 | 2006 | 74 | 0.260 |
Why?
|
| Eligibility Determination | 1 | 2005 | 17 | 0.250 |
Why?
|
| Role | 1 | 2005 | 5 | 0.250 |
Why?
|
| Empirical Research | 2 | 2003 | 8 | 0.250 |
Why?
|
| Bariatric Surgery | 1 | 2005 | 25 | 0.250 |
Why?
|
| Communication Barriers | 2 | 2006 | 22 | 0.240 |
Why?
|
| Health Care Coalitions | 2 | 2002 | 6 | 0.240 |
Why?
|
| Health Care Rationing | 2 | 1994 | 12 | 0.240 |
Why?
|
| Aged | 14 | 2017 | 10288 | 0.230 |
Why?
|
| Hospitalization | 2 | 2021 | 463 | 0.230 |
Why?
|
| Inservice Training | 1 | 2003 | 12 | 0.230 |
Why?
|
| Gastroplasty | 1 | 2003 | 11 | 0.230 |
Why?
|
| Cost Sharing | 3 | 2015 | 10 | 0.230 |
Why?
|
| Critical Care | 1 | 2004 | 107 | 0.220 |
Why?
|
| Research Support as Topic | 4 | 2008 | 26 | 0.220 |
Why?
|
| Evidence-Based Medicine | 2 | 2004 | 215 | 0.220 |
Why?
|
| Social Values | 2 | 2001 | 12 | 0.220 |
Why?
|
| Wounds and Injuries | 1 | 2006 | 249 | 0.220 |
Why?
|
| Insurance, Health, Reimbursement | 3 | 2009 | 15 | 0.220 |
Why?
|
| Health Status | 3 | 2015 | 397 | 0.210 |
Why?
|
| Automobile Driving | 1 | 2022 | 23 | 0.210 |
Why?
|
| Cost-Benefit Analysis | 3 | 2009 | 185 | 0.210 |
Why?
|
| Genetic Enhancement | 1 | 2002 | 4 | 0.200 |
Why?
|
| Freedom | 3 | 2003 | 3 | 0.200 |
Why?
|
| Economics, Medical | 1 | 2001 | 2 | 0.200 |
Why?
|
| Pediatrics | 1 | 2003 | 157 | 0.200 |
Why?
|
| Models, Economic | 1 | 2001 | 20 | 0.200 |
Why?
|
| Choice Behavior | 2 | 2015 | 87 | 0.200 |
Why?
|
| Reimbursement, Incentive | 4 | 2005 | 11 | 0.190 |
Why?
|
| Group Purchasing | 1 | 2001 | 1 | 0.190 |
Why?
|
| Hospital-Patient Relations | 1 | 2001 | 3 | 0.190 |
Why?
|
| Dissent and Disputes | 2 | 2015 | 3 | 0.190 |
Why?
|
| Genetics | 1 | 2000 | 4 | 0.180 |
Why?
|
| Travel | 1 | 2020 | 15 | 0.180 |
Why?
|
| Government | 2 | 2017 | 3 | 0.180 |
Why?
|
| Wisconsin | 1 | 2020 | 21 | 0.180 |
Why?
|
| Massachusetts | 2 | 2010 | 27 | 0.180 |
Why?
|
| Air Ambulances | 1 | 2020 | 10 | 0.180 |
Why?
|
| Program Development | 2 | 2011 | 96 | 0.180 |
Why?
|
| Emergency Service, Hospital | 1 | 2004 | 471 | 0.180 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 23 | 0.180 |
Why?
|
| Emergencies | 1 | 2020 | 47 | 0.180 |
Why?
|
| Poverty | 2 | 2011 | 111 | 0.170 |
Why?
|
| Disabled Persons | 1 | 2020 | 105 | 0.170 |
Why?
|
| Health Status Indicators | 1 | 2000 | 73 | 0.170 |
Why?
|
| Risk | 2 | 2016 | 318 | 0.160 |
Why?
|
| Random Allocation | 3 | 2003 | 218 | 0.150 |
Why?
|
| Iron Overload | 2 | 2008 | 38 | 0.150 |
Why?
|
| Colorado | 2 | 2012 | 41 | 0.150 |
Why?
|
| Qualitative Research | 2 | 2016 | 166 | 0.150 |
Why?
|
| Personal Autonomy | 2 | 1994 | 7 | 0.150 |
Why?
|
| Policy Making | 3 | 2003 | 20 | 0.140 |
Why?
|
| Preferred Provider Organizations | 1 | 2016 | 1 | 0.140 |
Why?
|
| Canada | 2 | 2007 | 56 | 0.140 |
Why?
|
| Insurance | 1 | 1996 | 1 | 0.140 |
Why?
|
| Judicial Role | 1 | 1996 | 1 | 0.140 |
Why?
|
| Social Control, Formal | 1 | 1996 | 4 | 0.130 |
Why?
|
| Ethnic Groups | 3 | 2007 | 476 | 0.130 |
Why?
|
| Negotiating | 1 | 2015 | 7 | 0.130 |
Why?
|
| Pedigree | 1 | 1996 | 140 | 0.130 |
Why?
|
| History, 20th Century | 2 | 2008 | 71 | 0.130 |
Why?
|
| Social Security | 1 | 2014 | 2 | 0.120 |
Why?
|
| State Medicine | 1 | 2014 | 3 | 0.120 |
Why?
|
| Professional Autonomy | 1 | 1994 | 6 | 0.120 |
Why?
|
| Government Programs | 1 | 2014 | 9 | 0.120 |
Why?
|
| Budgets | 1 | 2014 | 10 | 0.120 |
Why?
|
| Prenatal Care | 1 | 2015 | 51 | 0.120 |
Why?
|
| Socioeconomic Factors | 3 | 2011 | 420 | 0.120 |
Why?
|
| Ethical Analysis | 1 | 1994 | 1 | 0.120 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2013 | 2 | 0.120 |
Why?
|
| Organizational Innovation | 2 | 2005 | 31 | 0.120 |
Why?
|
| Symporters | 1 | 2013 | 12 | 0.120 |
Why?
|
| Adolescent | 3 | 2015 | 3511 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2013 | 28 | 0.110 |
Why?
|
| Glutathione | 1 | 2013 | 44 | 0.110 |
Why?
|
| Treatment Outcome | 3 | 2009 | 3294 | 0.110 |
Why?
|
| Lactic Acid | 1 | 2013 | 53 | 0.110 |
Why?
|
| Communications Media | 1 | 2013 | 4 | 0.110 |
Why?
|
| Independent Practice Associations | 2 | 2004 | 3 | 0.110 |
Why?
|
| Guideline Adherence | 1 | 2014 | 119 | 0.110 |
Why?
|
| Hospital Administration | 1 | 2013 | 13 | 0.110 |
Why?
|
| Uncompensated Care | 1 | 2013 | 4 | 0.110 |
Why?
|
| Hospital Costs | 1 | 2013 | 37 | 0.110 |
Why?
|
| Community Health Services | 1 | 2013 | 56 | 0.110 |
Why?
|
| Evaluation Studies as Topic | 2 | 2006 | 45 | 0.110 |
Why?
|
| Telephone | 2 | 2003 | 59 | 0.110 |
Why?
|
| Maryland | 1 | 2012 | 28 | 0.110 |
Why?
|
| Pregnancy | 1 | 2016 | 994 | 0.110 |
Why?
|
| Advisory Committees | 1 | 2012 | 31 | 0.100 |
Why?
|
| California | 1 | 2012 | 61 | 0.100 |
Why?
|
| Capitation Fee | 2 | 2002 | 3 | 0.100 |
Why?
|
| Diffusion of Innovation | 1 | 2012 | 34 | 0.100 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 3988 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2005 | 764 | 0.100 |
Why?
|
| Attitude | 2 | 2006 | 40 | 0.100 |
Why?
|
| National Health Programs | 1 | 2011 | 4 | 0.100 |
Why?
|
| Young Adult | 2 | 2017 | 2603 | 0.100 |
Why?
|
| Language | 2 | 2010 | 42 | 0.100 |
Why?
|
| Truth Disclosure | 2 | 2001 | 13 | 0.100 |
Why?
|
| Gatekeeping | 2 | 2005 | 2 | 0.100 |
Why?
|
| Congresses as Topic | 1 | 2011 | 40 | 0.100 |
Why?
|
| African Americans | 3 | 2007 | 1428 | 0.090 |
Why?
|
| Pilot Projects | 2 | 2017 | 537 | 0.090 |
Why?
|
| Prospective Payment System | 1 | 2010 | 9 | 0.090 |
Why?
|
| Retirement | 1 | 2010 | 11 | 0.090 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2010 | 28 | 0.090 |
Why?
|
| Reimbursement, Disproportionate Share | 1 | 2009 | 1 | 0.090 |
Why?
|
| Patient Care | 1 | 1990 | 31 | 0.090 |
Why?
|
| Iron | 2 | 2007 | 115 | 0.090 |
Why?
|
| Cost of Illness | 1 | 2009 | 70 | 0.090 |
Why?
|
| Organizational Policy | 2 | 2006 | 20 | 0.080 |
Why?
|
| Clinical Competence | 2 | 2002 | 325 | 0.080 |
Why?
|
| Cell Line | 1 | 2010 | 434 | 0.080 |
Why?
|
| Professional Practice | 1 | 2008 | 24 | 0.080 |
Why?
|
| Cardiology | 1 | 2010 | 99 | 0.080 |
Why?
|
| History, 19th Century | 1 | 2008 | 13 | 0.080 |
Why?
|
| Patient Education as Topic | 2 | 2007 | 271 | 0.080 |
Why?
|
| Europe | 1 | 2008 | 83 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2008 | 59 | 0.080 |
Why?
|
| Research Design | 1 | 2010 | 310 | 0.080 |
Why?
|
| Patient Participation | 1 | 2008 | 80 | 0.070 |
Why?
|
| Poverty Areas | 1 | 2007 | 5 | 0.070 |
Why?
|
| Logistic Models | 2 | 2010 | 777 | 0.070 |
Why?
|
| Education | 1 | 2006 | 39 | 0.070 |
Why?
|
| Income | 1 | 2006 | 61 | 0.070 |
Why?
|
| Safety | 1 | 2006 | 78 | 0.070 |
Why?
|
| Cross-Cultural Comparison | 1 | 2006 | 26 | 0.070 |
Why?
|
| Southeastern United States | 2 | 2004 | 79 | 0.070 |
Why?
|
| Patient-Centered Care | 1 | 2006 | 75 | 0.060 |
Why?
|
| Utilization Review | 1 | 2005 | 17 | 0.060 |
Why?
|
| Sampling Studies | 2 | 2002 | 43 | 0.060 |
Why?
|
| Quality Indicators, Health Care | 1 | 2005 | 59 | 0.060 |
Why?
|
| Decision Making, Organizational | 1 | 2005 | 4 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2011 | 1431 | 0.060 |
Why?
|
| European Continental Ancestry Group | 2 | 2007 | 1169 | 0.060 |
Why?
|
| Deductibles and Coinsurance | 1 | 2005 | 3 | 0.060 |
Why?
|
| Unnecessary Procedures | 1 | 2005 | 16 | 0.060 |
Why?
|
| Ethics, Clinical | 1 | 2005 | 8 | 0.060 |
Why?
|
| Drug Therapy | 1 | 2004 | 16 | 0.060 |
Why?
|
| Altruism | 2 | 1994 | 5 | 0.060 |
Why?
|
| Beneficence | 2 | 1994 | 3 | 0.060 |
Why?
|
| Professional-Family Relations | 1 | 2003 | 16 | 0.060 |
Why?
|
| Health Services Misuse | 1 | 2003 | 7 | 0.060 |
Why?
|
| Euthanasia, Active | 1 | 2003 | 1 | 0.060 |
Why?
|
| Suicide, Assisted | 1 | 2003 | 2 | 0.060 |
Why?
|
| Hospitals | 1 | 2004 | 98 | 0.060 |
Why?
|
| Coercion | 1 | 2003 | 4 | 0.050 |
Why?
|
| Organizational Case Studies | 1 | 2003 | 11 | 0.050 |
Why?
|
| Social Control Policies | 1 | 2003 | 3 | 0.050 |
Why?
|
| Drinking Behavior | 1 | 2022 | 10 | 0.050 |
Why?
|
| Euthanasia | 1 | 2002 | 1 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2003 | 184 | 0.050 |
Why?
|
| Social Responsibility | 1 | 2003 | 12 | 0.050 |
Why?
|
| Faculty, Medical | 1 | 2003 | 78 | 0.050 |
Why?
|
| Physicians, Family | 1 | 2002 | 16 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2002 | 109 | 0.050 |
Why?
|
| Sociology, Medical | 1 | 2001 | 2 | 0.050 |
Why?
|
| Uncertainty | 1 | 2001 | 10 | 0.050 |
Why?
|
| Preventive Health Services | 1 | 2002 | 44 | 0.050 |
Why?
|
| Office Visits | 1 | 2002 | 73 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2002 | 173 | 0.050 |
Why?
|
| Reward | 1 | 2002 | 64 | 0.050 |
Why?
|
| Risk Factors | 1 | 2009 | 3851 | 0.050 |
Why?
|
| Vaccination | 1 | 2022 | 136 | 0.050 |
Why?
|
| Professional Role | 1 | 2001 | 19 | 0.050 |
Why?
|
| Family | 1 | 2021 | 117 | 0.050 |
Why?
|
| Professional Competence | 1 | 2001 | 19 | 0.050 |
Why?
|
| Internet | 1 | 2002 | 195 | 0.050 |
Why?
|
| Emotions | 1 | 2001 | 56 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 1527 | 0.050 |
Why?
|
| Ethanol | 1 | 2022 | 186 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 504 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2003 | 916 | 0.040 |
Why?
|
| Weight Loss | 1 | 2003 | 465 | 0.040 |
Why?
|
| Questionnaires | 1 | 2000 | 3 | 0.040 |
Why?
|
| New Mexico | 1 | 2000 | 6 | 0.040 |
Why?
|
| Actuarial Analysis | 1 | 2000 | 12 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2004 | 306 | 0.040 |
Why?
|
| Iowa | 1 | 2000 | 9 | 0.040 |
Why?
|
| Minnesota | 1 | 2000 | 21 | 0.040 |
Why?
|
| Florida | 1 | 2000 | 37 | 0.040 |
Why?
|
| Continuity of Patient Care | 1 | 2001 | 69 | 0.040 |
Why?
|
| Ohio | 1 | 2000 | 58 | 0.040 |
Why?
|
| Fear | 1 | 2000 | 48 | 0.040 |
Why?
|
| Comprehension | 2 | 2010 | 19 | 0.040 |
Why?
|
| Prevalence | 1 | 2020 | 979 | 0.040 |
Why?
|
| Access to Information | 1 | 2017 | 13 | 0.040 |
Why?
|
| Public Sector | 1 | 1996 | 2 | 0.030 |
Why?
|
| Privacy | 1 | 1996 | 10 | 0.030 |
Why?
|
| Industry | 1 | 1996 | 15 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 1996 | 107 | 0.030 |
Why?
|
| Insurance Benefits | 1 | 2015 | 5 | 0.030 |
Why?
|
| Mutation | 2 | 2008 | 487 | 0.030 |
Why?
|
| Genotype | 2 | 2007 | 727 | 0.030 |
Why?
|
| Withholding Treatment | 1 | 1994 | 11 | 0.030 |
Why?
|
| Physician's Role | 1 | 1994 | 40 | 0.030 |
Why?
|
| Ethicists | 1 | 1994 | 1 | 0.030 |
Why?
|
| Paternalism | 1 | 1994 | 2 | 0.030 |
Why?
|
| Bioethics | 1 | 1994 | 2 | 0.030 |
Why?
|
| Glycolysis | 1 | 2013 | 20 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2013 | 23 | 0.030 |
Why?
|
| Metformin | 1 | 2013 | 22 | 0.030 |
Why?
|
| Cell Death | 1 | 2013 | 77 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 1994 | 47 | 0.030 |
Why?
|
| Transients and Migrants | 1 | 2017 | 291 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2013 | 128 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 57 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 83 | 0.030 |
Why?
|
| Protein Binding | 1 | 2013 | 201 | 0.030 |
Why?
|
| Homeostasis | 1 | 2013 | 132 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 137 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 268 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2004 | 686 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 261 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 323 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 725 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2013 | 598 | 0.020 |
Why?
|
| Reference Standards | 1 | 1990 | 32 | 0.020 |
Why?
|
| Ambulatory Care Facilities | 1 | 2010 | 83 | 0.020 |
Why?
|
| Total Quality Management | 1 | 2009 | 18 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 298 | 0.020 |
Why?
|
| Disease Notification | 1 | 2008 | 1 | 0.020 |
Why?
|
| Postal Service | 1 | 2008 | 7 | 0.020 |
Why?
|
| Transferrin | 1 | 2008 | 33 | 0.020 |
Why?
|
| Ferritins | 1 | 2008 | 46 | 0.020 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2008 | 59 | 0.020 |
Why?
|
| Linear Models | 1 | 2010 | 449 | 0.020 |
Why?
|
| Mice | 1 | 2013 | 2476 | 0.020 |
Why?
|
| Counseling | 1 | 2007 | 97 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2008 | 257 | 0.020 |
Why?
|
| Phenotype | 1 | 2007 | 635 | 0.020 |
Why?
|
| Asthma | 1 | 2008 | 298 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 409 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2004 | 72 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2004 | 293 | 0.010 |
Why?
|
| Communication | 1 | 2004 | 139 | 0.010 |
Why?
|
| Time and Motion Studies | 1 | 2002 | 6 | 0.010 |
Why?
|
| Animals | 1 | 2013 | 7450 | 0.010 |
Why?
|
| Quality of Life | 1 | 2006 | 924 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 2146 | 0.010 |
Why?
|